Literature DB >> 20053802

Abrupt regression of a meningioma after discontinuation of cyproterone treatment.

A M G Gonçalves1, P Page, V Domigo, J-F Méder, C Oppenheim.   

Abstract

The multiplicity of meningiomas or abrupt lesion growth in patients treated with cyproterone acetate suggests that this progestative treatment may promote lesion growth. We report the rapid regression of an incidental meningioma after discontinuation of a 10-year cyproterone acetate treatment. This unique observation suggests that conservative management of meningiomas may be the best option among users of high doses of cyproterone acetate, given that spontaneous regression may occur after hormonal treatment discontinuation.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20053802      PMCID： PMC7966109          DOI： 10.3174/ajnr.A1978

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  12 in total

1.  Growth of a meningioma in a transsexual patient after estrogen-progestin therapy.

Authors:  Roberto Gazzeri; Marcelo Galarza; Giovanni Gazzeri
Journal:  N Engl J Med       Date:  2007-12-06       Impact factor: 91.245

2.  Regression of intracranial meningioma following intratumoral hemorrhage.

Authors:  João Paulo C de Almeida; Rory J Petteys; Daniel M Sciubba; Gary L Gallia; Henry Brem
Journal:  J Clin Neurosci       Date:  2009-06-26       Impact factor: 1.961

3.  Risk of brain tumors associated with exposure to exogenous female sex hormones.

Authors:  Annette Wigertz; Stefan Lönn; Tiit Mathiesen; Anders Ahlbom; Per Hall; Maria Feychting
Journal:  Am J Epidemiol       Date:  2006-07-11       Impact factor: 4.897

4.  Meningiomas in lymphangioleiomyomatosis.

Authors:  J Moss; R DeCastro; N J Patronas; A Taveira-DaSilva
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

5.  Sex steroid and growth factor profile of a meningioma associated with pregnancy.

Authors:  Justin S Smith; Alfredo Quiñones-Hinojosa; Miranda Harmon-Smith; Andrew W Bollen; Michael W McDermott
Journal:  Can J Neurol Sci       Date:  2005-02       Impact factor: 2.104

6.  Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration.

Authors:  Jun Shimizu; Masayoshi Matsumoto; Etsuo Yamazaki; Masaharu Yasue
Journal:  Neurol Med Chir (Tokyo)       Date:  2008-05       Impact factor: 1.742

7.  Reproductive factors and risk of meningioma and glioma.

Authors:  Annette Wigertz; Stefan Lönn; Per Hall; Anssi Auvinen; Helle Collatz Christensen; Christoffer Johansen; Lars Klaeboe; Tiina Salminen; Minouk J Schoemaker; Anthony J Swerdlow; Tore Tynes; Maria Feychting
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

8.  Modulation of meningioma cell growth by sex steroid hormones in vitro.

Authors:  J R Jay; D T MacLaughlin; K R Riley; R L Martuza
Journal:  J Neurosurg       Date:  1985-05       Impact factor: 5.115

9.  Rapid growth and regression of intracranial meningiomas in lymphangioleiomyomatosis: case report.

Authors:  Eugenio Pozzati; Mino Zucchelli; Mario Schiavina; Paola Contini; Maria Pia Foschini
Journal:  Surg Neurol       Date:  2007-06-21

10.  Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.

Authors:  Y Matsuda; K Kawamoto; K Kiya; K Kurisu; K Sugiyama; T Uozumi
Journal:  J Neurosurg       Date:  1994-03       Impact factor: 5.115
View more
  11 in total

1.  Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience.

Authors:  Thomas Samoyeau; Marc Zanello; Alexandre Roux; Joseph Benzakoun; Henri Malaize; Sophie Peeters; Gilles Zah-Bi; Myriam Edjlali; Arnault Tauziede-Espariat; Edouard Dezamis; Eduardo Parraga; Fabrice Chrétien; Pascale Varlet; Geneviève Plu-Bureau; Catherine Oppenheim; Johan Pallud
Journal:  J Neurooncol       Date:  2021-01-15       Impact factor: 4.130

2.  Progestin-related WHO grade II meningiomas behavior-a single-institution comparative case series.

Authors:  Antoine Devalckeneer; Rabih Aboukais; Maxime Faisant; Philippe Bourgeois; Vannod-Michel Quentin; Claude-Alain Maurage; Fabienne Escande; Jean-Paul Lejeune
Journal:  Neurosurg Rev       Date:  2021-11-30       Impact factor: 3.042

3.  Meningioma in patients exposed to progestin drugs: results from a real-life screening program.

Authors:  Catherine Oppenheim; Joseph Benzakoun; Thomas Samoyeau; Corentin Provost; Alexandre Roux; Laurence Legrand; Edouard Dezamis; Geneviève Plu-Bureau; Johan Pallud
Journal:  J Neurooncol       Date:  2022-09-06       Impact factor: 4.506

4.  Spontaneous regression together with increased calcification of incidental meningioma.

Authors:  Kengo Hirota; Toshiyuki Fujita; Hiroyuki Akagawa; Hideaki Onda; Hidetoshi Kasuya
Journal:  Surg Neurol Int       Date:  2014-05-21

5.  Spontaneous Regression of an Incidental Spinal Meningioma.

Authors:  Ali Yilmaz; Zahir Kizilay; Ahmet Sair; Mucahit Avcil; Ayca Ozkul
Journal:  Open Access Maced J Med Sci       Date:  2015-12-21

6.  Regression of Intracranial Meningioma during Treatment with α1-Adrenoceptor Blocker.

Authors:  Einar August Hoegestoel; Jon Berg-Johnsen
Journal:  J Neurol Surg Rep       Date:  2016-03

7.  Possible Abscopal Effect Observed in Frontal Meningioma After Localized IMRT on Posterior Meningioma Resection Cavity Without Adjuvant Immunotherapy.

Authors:  Danielle Golub; Kevin Kwan; Jonathan P S Knisely; Michael Schulder
Journal:  Front Oncol       Date:  2019-10-18       Impact factor: 6.244

Review 8.  Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population.

Authors:  Gloria Aranda; Irene Halperin; Esther Gomez-Gil; Felicia A Hanzu; Núria Seguí; Antonio Guillamon; Mireia Mora
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-30       Impact factor: 5.555

9.  Unilateral proptosis and blindness caused by meningioma in a patient treated with cyproterone acetate.

Authors:  Celine Sys; Philippe Kestelyn
Journal:  GMS Ophthalmol Cases       Date:  2015-06-17

10.  Multiple meningiomas in two male-to-female transsexual patients with hormone replacement therapy: A report of two cases and a brief literature review.

Authors:  Rahul Raj; Miikka Korja; Päivi Koroknay-Pál; Mika Niemelä
Journal:  Surg Neurol Int       Date:  2018-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.